Abstract
Candida albicans (C. albicans) is a ubiquitous commensal in the mammalian flora and the most prevalent fungal pathogen of humans. As an opportunistic fungus, C. albicans can cause mucosal and invasive infections. Invasive candidiasis infected by C. albicans is a leading cause of perioperative death in immunocompromised and immunodeficient patients. The morphological change from the yeast to the mycelium plays a key role in the pathogenesis of C. albicans. C-type lectin receptors (CLRs), including Dectin-1, Dectin-2, Dectin-3, Mincle, and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin, are among the pattern recognition receptors expressed by innate immune cells that can recognize C. albicans. The emergence of drug-resistant C. albicans put pressure on the healthcare system, whereby CLRs have also attracted extensive attention from physicians. Thus, in this article, we discuss the interaction between CLRs and C. albicans and the treatment prospects of CLRs on anti-C. albicans.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
